Pharmaceutical Residues in Human Urine from Patients Under Antiretroviral Regimens and Self-Reported Healthy Individuals Before and After Three Months' Storage: Implication for Agricultural Reuse in Pretoria, South Africa.
- 1Department of Biology and Environmental Sciences, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
- 2Discipline of Chemistry, School of Agriculture and Science, College of Agriculture Engineering and Science, University of KwaZulu-Natal, Westville, Durban 4000, South Africa.
- 3Department of Health Sciences and The Water School, Florida Gulf Coast University, Fort Myers, FL 33965, USA.
Abstract
Background/Objectives: Pharmaceutical residues in human urine have raised serious concerns about the safe reuse of urine in agriculture. The current study investigates and compares the concentrations of pharmaceuticals in urine samples collected from male patients undergoing active antiretroviral regimens and self-reported "healthy individuals" at a government hospital in Pretoria, South Africa, and determines how the residues changed during three months of ambient storage, which is the usual recommendation before use in agriculture. Methods: The urine samples were collected in a plastic bottle to prevent fecal contamination, and 15 targeted compounds were analyzed using solid-phase extraction and liquid chromatography-mass spectrometry. The linearity ranged from 0.9910 to 0.9999, 75.5% to 99.1% for recovery, and intra-day and inter-day precision were below 6%. The urine from each group was collected into one pooled sample and then analyzed both pre- and post-storage. Results: Thirteen pharmaceuticals were detected in urine from patients on regular medication before storage; in "healthy individuals", detections rose from eight to twelve after storage. Concentrations in the composite samples after storage were higher for some of the compounds but lower for others, including caffeine, nevirapine, prednisolone and 17α-ethinylestradiol. Metformin was highest overall at 1186.25 µg/L and remained at 806.68 µg/L after storage. The highest concentration for all the pharmaceuticals was reported for metformin, with a value of 1186.25 µg/L, occurring in the group of patients on a regular regimen. There could be a possibility that the rise can be attributed to the hydrolysis of conjugated metabolites during storage; however, no analysis of conjugates was carried out. Conclusions: This study shows the need for appropriate treatment of human urine prior to its reuse as fertilizer and echoes the importance of further research into human exposure pathways and effective pharmaceutical removal strategies.
Related
- An overlooked pool of hydrogen stored in humic matter revealed by isotopic exchange: implication for radioactive ³H contamination
- Temporal and spatial variability in mudflat and mangrove foraminiferal eDNA communities in subtropical environments and their implication for sea-level reconstruction
- Light absorption properties and composition of water-soluble brown carbon in North China Plain: implication for an enhancing role of nitrogenous organic compounds
- How does soil texture mediate the impacts of antibiotic residues in manure on soil nitrogen cycling communities and nitrogen dynamics?
- Removal and biodegradation of the pharmaceutical pollutant cortisone acetate by Scenedesmus obtusus under varying salinity conditions
BibTeX
@article{lizbelt2026pharmaceutical,
title = {{Pharmaceutical Residues in Human Urine from Patients Under Antiretroviral Regimens and Self-Reported Healthy Individuals Before and After Three Months' Storage: Implication for Agricultural Reuse in Pretoria, South Africa.}},
author = {Mugivhisa Liziwe Lizbelt and Baloyi Khanyi Faith and Oluwaseun Mary Oladeji and Olatunde Stephen Olatunji and Joshua Oluwole Olowoyo},
journal = {Biotech (Basel (Switzerland))},
year = {2026},
month = oct,
doi = {10.3390/biotech15040092},
url = {https://europepmc.org/article/MED/42930069},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pharmaceutical Residues in Human Urine from Patients Under Antiretroviral Regimens and Self-Reported Healthy Individuals Before and After Three Months' Storage: Implication for Agricultural Reuse in Pretoria, South Africa.
AU - Mugivhisa Liziwe Lizbelt
AU - Baloyi Khanyi Faith
AU - Oluwaseun Mary Oladeji
AU - Olatunde Stephen Olatunji
AU - Joshua Oluwole Olowoyo
PY - 2026
DA - 2026/10/13
JO - Biotech (Basel (Switzerland))
DO - 10.3390/biotech15040092
UR - https://europepmc.org/article/MED/42930069
AB - Background/Objectives: Pharmaceutical residues in human urine have raised serious concerns about the safe reuse of urine in agriculture. The current study investigates and compares the concentrations of pharmaceuticals in urine samples collected from male patients undergoing active antiretroviral regimens and self-reported "healthy individuals" at a government hospital in Pretoria, South Africa, and determines how the residues changed during three months of ambient storage, which is the usual recommendation before use in agriculture. Methods: The urine samples were collected in a plastic bottle to prevent fecal contamination, and 15 targeted compounds were analyzed using solid-phase extraction and liquid chromatography-mass spectrometry. The linearity ranged from 0.9910 to 0.9999, 75.5% to 99.1% for recovery, and intra-day and inter-day precision were below 6%. The urine from each group was collected into one pooled sample and then analyzed both pre- and post-storage. Results: Thirteen pharmaceuticals were detected in urine from patients on regular medication before storage; in "healthy individuals", detections rose from eight to twelve after storage. Concentrations in the composite samples after storage were higher for some of the compounds but lower for others, including caffeine, nevirapine, prednisolone and 17α-ethinylestradiol. Metformin was highest overall at 1186.25 µg/L and remained at 806.68 µg/L after storage. The highest concentration for all the pharmaceuticals was reported for metformin, with a value of 1186.25 µg/L, occurring in the group of patients on a regular regimen. There could be a possibility that the rise can be attributed to the hydrolysis of conjugated metabolites during storage; however, no analysis of conjugates was carried out. Conclusions: This study shows the need for appropriate treatment of human urine prior to its reuse as fertilizer and echoes the importance of further research into human exposure pathways and effective pharmaceutical removal strategies.
SN - 2673-6284
ER -